Emmy L. Tran

Safety of Antimicrobials During Pregnancy: A Systematic Review of Antimicrobials Considered for Treatment and Postexposure Prophylaxis of Plague.

Philip Smith, P. Yu, D. Meaney-Delman, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Field Placement Approach to Enhance State and Local Capacity for Opioid-Related Issues Affecting Pregnant and Postpartum People and Infants Prenatally Exposed to Opioids and Other Substances.

L. Romero, W. Barfield, C. Kroelinger, 2022, Journal of women's health.

Opioid prescription claims among women aged 15-44 years-United States, 2013-2017.

Meghan T. Frey, Jean Y. Ko, S. Gilboa, 2021, Journal of opioid management.

Alcohol Use and Co-Use of Other Substances Among Pregnant Females Aged 12–44 Years — United States, 2015–2018

C. Denny, S. Gilboa, G. Guy, 2020, MMWR. Morbidity and mortality weekly report.

Systematic Review: Polysubstance Prevalence Estimates Reported during Pregnancy, US, 2009–2020

C. Denny, Lucinda J England, Emmy L. Tran, 2023, Maternal and Child Health Journal.

Antibiotics Dispensed to Privately Insured Pregnant Women with Urinary Tract Infections — United States, 2014

S. Gilboa, J. Reefhuis, K. Arnold, 2018, MMWR. Morbidity and mortality weekly report.

Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997–2011

M. Werler, A. Mitchell, S. Gilboa, 2019, Birth defects research.

Receipt of American Heart Association–Recommended Preconception Health Care Among Privately Insured Women With Congenital Heart Defects, 2007–2013

S. Farr, M. Oster, M. Gurvitz, 2019, Journal of the American Heart Association.

The MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment of Opioid Use Disorder During Pregnancy (MAT-LINK): Surveillance Opportunity.

S. Gilboa, D. Meaney-Delman, Shin Y. Kim, 2020, Journal of women's health.

Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014–2018)

W. Nembhard, M. Browne, E. Ailes, 2023, Pharmacoepidemiology and drug safety.

Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021

Juneka H Rembert, K. Sward, S. Gilboa, 2023, Morbidity and mortality weekly report. Surveillance summaries.